PT - JOURNAL ARTICLE AU - Vinall, Maria ED - Philis-Tsimikas, Athena TI - Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Uncontrolled Patients with Type 2 Diabetes on Oral Agents DP - 2012 Dec 01 TA - MD Conference Express PG - 20--20 VI - 12 IP - 16 4099 - http://mdc.sagepub.com/content/12/16/20.short 4100 - http://mdc.sagepub.com/content/12/16/20.full AB - Insulin degludec is superior to sitagliptin in improving glycemic control in patients with type 2 diabetes mellitus uncontrolled by oral antidiabetic drugs (OADs). This article discusses the results of the comparison of NN1250 with Sitagliptin in Subjects with Type 2 Diabetes Never Treated with Insulin [BEGINĀ®: EARLY; NCT01046110] trial that compared basal insulin with a dipeptidyl peptidase-4 inhibitor as an add-on to OADs.